Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspective. [electronic resource]
Producer: 20101208Description: 207-16 p. digitalISSN:- 1573-7241
- Aspirin -- adverse effects
- Clopidogrel
- Hemorrhage -- chemically induced
- Humans
- Platelet Aggregation Inhibitors -- adverse effects
- Randomized Controlled Trials as Topic -- methods
- Retrospective Studies
- Risk
- Thrombosis -- prevention & control
- Ticlopidine -- adverse effects
- Time Factors
- Vascular Diseases -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.